CKD-EPI 2021: Checking an eGFR Result Before Acting

Check CKD-EPI 2021 inputs, reproduce an adult eGFR example and interpret chronicity, muscle-mass bias and medication thresholds without turning an estimate into a prescription.
Editorial record

This source-linked educational article has been updated through AI-assisted evidence checks and editorial review. Verify information against current guidance and local protocols before applying it to patient care.

Citation methodology

An eGFR is an estimate of filtration, not a direct measurement and not a diagnosis on its own. This guide addresses the calculation and its interpretation in adults; equation changes over time are a separate problem.

Check the Inputs

The 2021 creatinine equation is:

eGFR = 142 x min(Scr/k, 1)^a x max(Scr/k, 1)^(-1.200) x 0.9938^age x F

Use creatinine in mg/dL and age in years. For the female equation, k = 0.7, a = -0.241, and F = 1.012; for the male equation, k = 0.9, a = -0.302, and F = 1. The output is mL/min/1.73 m2. These are model inputs, not a claim that sex captures all individual biological variation. NIDDK adult equations.

Worked Calculation

For a fictional 60-year-old using the male equation with creatinine 1.2 mg/dL:

  • Scr/k = 1.2/0.9 = 1.3333
  • The minimum term is 1.
  • 142 x (1.2/0.9)^(-1.2) x 0.9938^60 = 69.23

Report approximately 69 mL/min/1.73 m2, not a spurious string of decimal places. The arithmetic does not establish chronic kidney disease.

Interpret Chronicity and Albuminuria

A result in the 60-89 range is not CKD without other evidence of kidney damage. CKD requires abnormalities persisting for at least 3 months; reduced filtration below 60 or persistent markers such as albuminuria can qualify. Interpret cause, GFR category, and albuminuria together. Do not infer chronicity from one unexpectedly low result. KDIGO 2024 CKD guideline, Chapter 1.

Recognize When Creatinine Misleads

Low muscle mass can lower creatinine and make creatinine-based eGFR overestimate filtration. High muscle mass can have the opposite effect. Rapidly changing creatinine also undermines steady-state interpretation. When the result is discordant or close to a consequential decision threshold, consider creatinine-cystatin C estimation or measured GFR as appropriate. Combining the two markers improved accuracy in the 2021 development study, but is not infallible. Inker and colleagues; NIDDK limitations and drug-dosing guidance.

Do not convert an eGFR category into a blanket medication instruction. Labels can specify different estimates, indications, and thresholds. In particular, an SGLT2 inhibitor is not automatically contraindicated simply because eGFR falls below 20 mL/min/1.73 m2 after initiation. Published KDIGO 2024 guidance allows continuation unless treatment is not tolerated or kidney replacement therapy begins, and separately advises considering temporary withholding during prolonged fasting, surgery, or critical illness. This is not permission to start or continue a medicine without individual assessment. KDIGO, practice points 3.7.1-3.7.2.